Colorectal neoplasia prophylaxis

Details Colorectal neoplasia prophylaxis Colorectal neoplasia prophylaxis

2006-10-03

2006-10-03

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S002600, C514S414000, C514S183000, C514S359000, C514S408000, C514S410000, C514S412000, C536S018700, C536S022100, C536S023100, C435S004000, C435S006120, C435S325000, C435S041000, C424S156100, C424S155100, C424S243100

Reexamination Certificate

active

07115577

ABSTRACT:
Development of colorectal neoplasia in a patient subject or predisposed to colorectal neoplasia is reduced by the steps of (a) determining a patient is subject or predisposed to colorectal neoplasia; and (b) enterically delivering into the gut of the person an effective amount of an aminoglycoside antibiotic having poor gut absorption, whereby the development of the colorectal neoplasia is reduced as compared with otherwise similar non-treated patients.

REFERENCES:
patent: 5614502 (1997-03-01), Flotte et al.
patent: 6482802 (2002-11-01), Hu et al.
patent: 6846807 (2005-01-01), Graff et al.

Affiliated with

Also associated with

Rating

Colorectal neoplasia prophylaxis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Colorectal neoplasia prophylaxis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colorectal neoplasia prophylaxis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3619443